Observational studyScientific reports2023

Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease.

Weiwei Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.